 |
| Implications |
- |
The result overwhelmingly favored the supplement of allicin as a preventive measure, demonstrated accelerated relief and reduction in the severity of the symptoms |
- |
A reduced likelihood of becoming re-infected with other viral strains indicated general improvements in the immune system with the active supplements |
|
|
 |
|
2. Antimicrobial Effects: Research Summary |
 |
 |
 |
 |
|
 |
|
Antimicrobial effects |
 |
Garlic is effective against a wide range of both Gram positive and negative bacteria, including:
- |
Salmonella:
Normally causes septicemia and produces typhoid or typhoid-like fever in humans. |
- |
Staphylococcus, Clostridium
Food poisoning. |
- |
Streptococcus
Causes septic sore throat and scarlet fever as well as other pyrogenic and septicemic infections. |
- |
Klebsiella, Proteus, Escherichia
Causes gastroenteritis, cute and chronic gastrointestinal disease. |
- |
Bacillus
Responsible for foodborne illness |
- |
Mycobacterium
The cause paralytic illness, wide range of symptoms from
food poisoning to gas gangrene. |
- |
Helicobacter Pylori
The cause of gastric ulcer. |
|
 |
 |
 |
 |
|
 |
|
 |
 |
|
 |
|
Immune effects |
 |
Garlic can stimulate and boost human immune system.
- |
Increases number of lymphocytes
A type of white blood cell involved in the human body's immune system. |
- |
Increases number of phagocytosis
Serve to remove foreign bodies and thus fight infection. |
- |
Increases natural killer cell activity
Also known as NK cells, K cells, and killer cells, these are a type of lymphocyte (a white blood cell) and a component of innate immune defense. These cells do not destroy the attacking microorganisms directly; they attack infected cells and possible cancerous cells. |
- |
Increases antibody titers
Antibody titer is a test that measures the presence and
amount of antibodies in blood. These antibodies may be against a particular type of tissue, cell, bacteria, virus, or
other external substance. |
|
For more information on bacterial, viruses, visit: http://www.cfsan.fda.gov/~mow/intro.html
|
 |